Viewing StudyNCT06413745

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-19 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06413745
Status: RECRUITING
Last Update Posted: 2024-07-08
First Post: 2024-05-09
Brief Title: Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer
Sponsor: Jiangsu HengRui Medicine Co Ltd
Organization: Jiangsu HengRui Medicine Co Ltd
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
HER2 Expression Amplification in Patients With Biliary Tract Cancer
Keywords: